Stealing With Our Eyes Open
Drug Topics
FEBRUARY 21, 2024
How much longer can independent pharmacists survive with the current method of reimbursement?
Wed.Feb 21, 2024
689 
Behind the breakthrough cancer therapy that just won a historic FDA nod
PharmaVoice
FEBRUARY 21, 2024
The first-of-its-kind TIL therapy for solid tumors developed by Iovance Biotherapeutics won FDA approval last week.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma
Drug Topics
FEBRUARY 21, 2024
The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
4 biotechs to watch in 2024
PharmaVoice
FEBRUARY 21, 2024
A splashy IPO, first-in-class treatments and upcoming approval dates are a few reasons we’ve got our eyes on these biotechs this year.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Differentiate Your Pharmacy With Unique Product, Service Offerings
Drug Topics
FEBRUARY 21, 2024
Offering services such as point-of-care testing and bundled products marketed as recovery kits can increase customer loyalty.
NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease
STAT
FEBRUARY 21, 2024
Alison Sbrana was in the belly of an opera when her life changed. Down in the pit, surrounded by fellow orchestra members, she’d been straining to play her flute for half the show. As performers overhead enveloped the audience in arias, Sbrana felt like the Hulk was pulling on the tendons in the right side of her neck. “I begged anybody for meds at intermission,” she said.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb
STAT
FEBRUARY 21, 2024
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not reach the operating room tucked into the sprawling Parnassus Heights hospital complex. In there, the light was all cold and blue fluorescence washing over the sea of scrub caps huddled around an anesthetized young woman on a gurney.
An Interview with Dr. Filmon Emnetu, PharmD, RPh
Drug Topics
FEBRUARY 21, 2024
Dr. Filmon Emnetu, PharmD, RPh, is the global clinical trial project manager at Eli Lilly.
STAT+: Scientists take a (small) step toward universal antivenom
STAT
FEBRUARY 21, 2024
Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of sub-lethal doses of venom from various local snakes, wait for them to develop an immune response, tap their blood, purify out antibodies, bottle, and freeze. This vampiric, century-old process still reigns because of the unique scientific challenge posed by snake venoms.
The Gut Microbiome Looks Different for People With Treatment-Resistant Schizophrenia
Pharmacy Times
FEBRUARY 21, 2024
Investigators suggested that this difference is caused by a common medication for treatment-resistant schizophrenia.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
STAT
FEBRUARY 21, 2024
People with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management, hopeful periods of remission often followed by relapses, but rarely a lasting fix for the way their immune system attacks healthy cells. If the immune system is an army, then those with conditions like lupus, multiple sclerosis, or rheumatoid arthritis are often fighting a never-ending war of friendly fire.
Parasite That Causes Malaria Extracts Fatty Acids From Human Hosts for Growth
Pharmacy Times
FEBRUARY 21, 2024
Malaria has a large global burden, affecting hundreds of millions of people each year.
Opinion: How Medicare leaves Puerto Ricans behind
STAT
FEBRUARY 21, 2024
When I accompany my father to his regular cardiologist appointment in Puerto Rico, worry and sadness always come along with us. While treatment has kept his health stable, I am still troubled that he always has to ask his doctor for medication samples. If he lived in any of the 50 states, Medicare would have provided coverage for his medical needs. But because he lived in Puerto Rico, Medicare is far less useful to him.
Clinical research is about trial and error
pharmaphorum
FEBRUARY 21, 2024
Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Hospitals race to adopt generative AI, even as regulators struggle to keep up with the risks
STAT
FEBRUARY 21, 2024
Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of money, or automate administrative tasks crucial to connecting patients with timely services. Rohit Chandra, chief digital officer of the Cleveland Clinic, said generative AI can accomplish all these things.
UnitedHealth, HAC study: How social health factors impact employer plans
Fierce Healthcare
FEBRUARY 21, 2024
Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper. | Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper.
The evolution of clinical research: embracing new delivery models in the UK
pharmaphorum
FEBRUARY 21, 2024
Explore the evolution of clinical research in the UK, including the role of NIHR and Direct Delivery Teams in embracing new delivery models. Join our informative webinar to learn more.
Emerging Markets Offer Pharma Its Next Growth Opportunity
Pharmacy Times
FEBRUARY 21, 2024
National governments and global non-governmental organizations are trying to expand access to essential medicines and treatments in developing countries.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: DarioHealth acquires Twill, hoping it’s a shortcut to profitability
STAT
FEBRUARY 21, 2024
DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.
FDA Approves sBLA for Reduced Dosing Frequency of Teclistamab-cqyv for Patients With RRMM
Pharmacy Times
FEBRUARY 21, 2024
Teclistamab was previously approved in October 2022 for the treatment of adult patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.
Novavax dodges COVID vaccine refund by settling Gavi arbitration for up to $400M
Fierce Pharma
FEBRUARY 21, 2024
On the heels of a turbulent 2023 in which Novavax’s very existence was at stake, the beleaguered vaccine maker has new reason to be optimistic about the future. | Novavax has reached a settlement with Gavi, the Vaccine Alliance ending arbitration tied to a 2021 advance purchase agreement around its prototype COVID-19 vaccine NVX-CoV2373. Had Novavax lost the arbitration, the company might have had to refund nearly $700 million.
Long-Acting Injectable Cabenuva Found More Effective Than Daily ART at Suppressing HIV in Patients With Adherence Challenges
Pharmaceutical Commerce
FEBRUARY 21, 2024
Cabenuva (cabotegravir + rilpivirine) showed superior efficacy in maintaining viral load suppression in patients with HIV compared with standard of care daily oral antiretroviral treatment.
Mobile ADHD awareness game launches in Germany
pharmaphorum
FEBRUARY 21, 2024
Attention-deficit hyperactivity disorder (ADHD) in adults is not well understood and highly underdiagnosed, but the developers of a mobile game designed to raise awareness hope to shine a light on the struggles of people struggling with the condition.
MA enrollees constrained by prior auth but docs more likely to ask about health assessments: report
Fierce Healthcare
FEBRUARY 21, 2024
Medicare Advantage (MA) beneficiaries are more likely than traditional Medicare enrollees to experience delays in care while they wait for prior authorization approval, but MA members are likely to | Medicare Advantage and traditional Medicare enrollees experience similar access to services and similar challenges, a report from the Commonwealth Fund concluded.
United sues FDA to try to block rival’s drug application
pharmaphorum
FEBRUARY 21, 2024
United sues FDA for allowing a marketing application for a competitor to its top-seller Tyvaso, filed by Liquidia, that sidesteps established procedures
Actually Wegovy is good for dialysis companies, dialysis provider says
STAT
FEBRUARY 21, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at the legacy of a pharma CEO, yet more biotech layoffs, and a reprieve from the GLP-1 panic.
Digital health firms DarioHealth and Twill merge
pharmaphorum
FEBRUARY 21, 2024
DarioHealth has bought fellow digital health company Twill in a move that combines their chronic disease and mental health platforms.
Alabama hospital pauses IVF treatments in wake of ruling saying frozen embryos are children
STAT
FEBRUARY 21, 2024
MONTGOMERY, Ala. — A large Alabama hospital paused in vitro fertilization treatments Wednesday as health care providers weigh the impact of a state court ruling that frozen embryos are the legal equivalent of children. The University of Alabama at Birmingham health system said in a statement that it must evaluate whether its patients or doctors could face criminal charges or punitive damages for undergoing IVF treatments.
Laura Geller Beauty ushers in new era on the heels of product milestone
Drug Store News
FEBRUARY 21, 2024
DSN spoke to Laura Geller about its "Let’s Face It” campaign, the 20th anniversary of the Baked Balance-n-Brighten Color Correcting Foundation and a new summer product launch.
From Prinicpal to Univo IRB, Julie Blasingim on a mission to revolutionize research ethics
Outsourcing Pharma
FEBRUARY 21, 2024
This week Univo IRB was announced as the new company name for Principal IRB.
Aetna Better Health of Illinois continues to address health disparities
Drug Store News
FEBRUARY 21, 2024
Aetna Better Health of Illinois is hosting Community Health Councils and introducing new benefits to eliminate barriers to achieving better physical and mental health.
Is it safe to take omeprazole during pregnancy?
The Checkup by Singlecare
FEBRUARY 21, 2024
Pregnancy can be an exciting time, but it’s not without an unpleasant side effect or two. Up to half of pregnant women experience gastroesophageal reflux disease (GERD) , also known as indigestion or heartburn. There are many medications and natural remedies for acid reflux. Prilosec ( omeprazole ) is a commonly used over-the-counter (OTC) heartburn medication.
What are consumers’ attitudes about OTCs?
Drug Store News
FEBRUARY 21, 2024
Recent data from YouGov Profiles reveals that nearly half of Americans (47%) buy OTC drugs as required rather than stocking up, followed by 39% who keep a stock of medications but buy others when necessary.
Let's personalize your content